Respirology

Get the info you need on this new drug, part of our drug news roundup for April.

From Apple Watches to cognitive benefits, how much do you know about the diagnosis and treatment of obstructive sleep apnea?

McMaster experts release comprehensive evidence-based guidelines for diagnosis, management, prevention and treatment of ‘long COVID.’

The National Advisory Committee on Immunization recently issued an updated statement on the use of respiratory syncytial virus vaccines in older adults.

Large cohort study finds patients taking GLP-1 RAs undergoing common surgical procedures have no increased risk of postoperative aspiration pneumonia.

National Advisory Committee on Immunization’s update also addresses use of new RSV mRNA vaccine (mResvia) and an expanded age range for Arexvy. 

NACI recommended that seniors who are 80 years and older, residents of long-term care homes, and adults and children six months and older who are moderately to severely immunocompromised should get two doses of COVID-19 vaccine per year.

Study compares twice-daily budesonide–glycopyrronium–formoterol (Breztri) metered-dose inhaler to daily fluticasone–umeclidinium–vilanterol (Trelegy) dry powder inhaler.